Skip to main content
Clinical Trials/NCT04344990
NCT04344990
Completed
Not Applicable

Comparison Study of Three Different Methods of Postoperative Pain Management After Total Knee Arthroplasty

University Hospital of Patras1 site in 1 country72 target enrollmentJune 29, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Postoperative Pain
Sponsor
University Hospital of Patras
Enrollment
72
Locations
1
Primary Endpoint
Postoperative analgesia
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The study compares three different analgesic techniques in order to determine which one serves as the optimal method for postoperative pain management after Total Knee Arthroplasty in patients suffering from Osteoarthritis

Detailed Description

Prospective, randomized, controlled study. Approval of the study from the University Hospital of Patras Ethics Committee. The Total Knee Arthroplasty procedure is performed always from the same team of Orthopedic surgeons who follow the same technique in each patient for the arthroplasty and the placement of the intraarticular catheter as well. The same team of Anesthesiologists (two Anesthesiologists) performs always the same technique for each analgesic method and is responsible for the patients' perioperative condition concerning anesthesia and analgesia. Preoperatively, one hour prior to the surgery, all patients receive preemptive multimodal analgesia in the following way; 40mg Parecoxib (iv), 1gr Paracetamol (iv), 150mg Pregabalin (po), 8mg Dexamethasone (iv) και 50mg Ranitidine (iv). All patients receive subarachnoid anesthesia with Ropivacaine 0.75% (7,5mg/ml) in a dosage of 2-3ml titrated according to patient's age and height. Three groups 1. Continuous epidural infusion (control group) with Ropivacaine 0.2% + clonidine 150μg. 2. Continuous femoral nerve blockade infusion with Ropivacaine 0.2% + clonidine 150μg. 3. Continuous intraarticular infusion with Ropivacaine 0.2% + clonidine 150μg. All the catheters remain for 48 hours while the infusion rate is 2ml/h + PCA with 0,5ml/15min and lock-out maximum dose 4/h in total volume of 150ml. Postoperatively all patients also receive; Parecoxib, Paracetamol, Pregabalin, and Ranitidine up to the third postoperative day (doses titrated). Rescue analgesia: Tramadol Chloride 50-100mg x 2 /24h depending on patient's age and medical history.

Registry
clinicaltrials.gov
Start Date
June 29, 2015
End Date
October 30, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Hospital of Patras
Responsible Party
Principal Investigator
Principal Investigator

Georgios Karpetas

Anesthesiologist MD

University Hospital of Patras

Eligibility Criteria

Inclusion Criteria

  • Patients scheduled for unilateral total knee arthroplasty (TKA) to treat knee osteoarthritis (OA)
  • Fully conversant in the Greek language
  • Written informed consent to participate in the trial

Exclusion Criteria

  • Age less than 50 years and greater than 85 years.
  • ASA score \>III
  • Subarachnoid anesthesia failure
  • Hypersensitivity/ allergy to certain agent used
  • Participation in other research/ study
  • Severe mental disease (schizophrenia, major depression, severe bipolar disorder, substance abuse)

Outcomes

Primary Outcomes

Postoperative analgesia

Time Frame: Up to 3 days

Pain scores, during rest and movement (active and passive) according to NRS (Numeric Rating Scale) right after the end of the surgery and 2, 4, 6, 12, 24, 36, 48, 60 and 72 hours later (postoperatively)

Secondary Outcomes

  • Mobilization(Up to 3 days)
  • LOS(Up to 3 months)

Study Sites (1)

Loading locations...

Similar Trials